• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

BI-3406 Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5753960

BI-3406 is an orally active, highly potent and selective between KRAS and Son of Sevenless 1 (SOS1) interaction inhibitor(IC50 of 6nM),with anticancer activity. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
BI-3406, Inhibitor
Full Product Name
BI-3406
Product Gene Name
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
462.46
Solubility
DMSO: 95mg/ml (205.42mM) Need ultrasonic
Ethanol: 100mg/mL (216.23mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C23H25F3N4O3
SMILES
COC1=C(O[C@H]2CCOC2)C=C2C(N[C@H](C)C3=CC(=CC(N)=C3)C(F)(F)F)=NC(C)=NC2=C1
CAS Number
2230836-55-0
Target & IC50
KRAS-SOS1: ic50 6nM

Product Categories/Family for BI-3406, inhibitor

Structure of BI-3406, inhibitor

BI-3406 Inhibitor – Cat# MBS5753960

Product References and Citations for BI-3406, inhibitor

Michael Gmachl, et al. Novel benzylamino substituted quinazolines and derivatives as sos1 inhibitors. WO2018115380A1.
Marco H Hofmann, et al. Abstract PL06-01: Discovery of BI-3406: A potent and selective SOS1::KRAS inhibitor opens a new approach for treating KRAS-driven tumors. December 2019.
Marco H Hofmann, et al. Abstract PL06-01: Discovery of BI-3406: A potent and selective SOS1::KRAS inhibitor opens a new approach for treating KRAS-driven tumors. December 2019.
Michael Gmachl, et al. Novel benzylamino substituted quinazolines and derivatives as sos1 inhibitors. WO2018115380A1.

Other Notes

Small volumes of BI-3406, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for BI-3406 purchase

MBS5753960 is an inhibitor targeting BI-3406.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000